Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

Clinical trial NCT03081481 · COMPLETED

Trial details

NCT number: NCT03081481
Sponsor: Sophiris Bio Corp
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2017-06-07
Primary completion: 2018-11-28
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.